vs
Side-by-side financial comparison of Dexcom (DXCM) and KB HOME (KBH). Click either name above to swap in a different company.
KB HOME is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Dexcom). Dexcom runs the higher net margin — 21.2% vs 6.0%, a 15.2% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -15.3%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 7.4%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
KB Home is an American homebuilding company founded in 1957 as Kaufman & Broad in Detroit, Michigan. It was the first company to be traded on the New York Stock Exchange as a home builder. Its headquarters are in Los Angeles, California.
DXCM vs KBH — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.7B |
| Net Profit | $267.3M | $101.5M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 6.0% |
| Revenue YoY | 21.6% | -15.3% |
| Net Profit YoY | 153.6% | -46.7% |
| EPS (diluted) | $0.67 | $1.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.7B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $994.2M | $1.8B | ||
| Q2 24 | $1.0B | $1.7B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $101.5M | ||
| Q3 25 | $283.8M | $109.8M | ||
| Q2 25 | $179.8M | $107.9M | ||
| Q1 25 | $105.4M | $109.6M | ||
| Q4 24 | $151.7M | $190.6M | ||
| Q3 24 | $134.6M | $157.3M | ||
| Q2 24 | $143.5M | $168.4M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 6.0% | ||
| Q3 25 | 23.5% | 6.8% | ||
| Q2 25 | 15.5% | 7.1% | ||
| Q1 25 | 10.2% | 7.9% | ||
| Q4 24 | 13.6% | 9.5% | ||
| Q3 24 | 13.5% | 9.0% | ||
| Q2 24 | 14.3% | 9.9% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.55 | ||
| Q3 25 | $0.70 | $1.61 | ||
| Q2 25 | $0.45 | $1.50 | ||
| Q1 25 | $0.27 | $1.49 | ||
| Q4 24 | $0.37 | $2.50 | ||
| Q3 24 | $0.34 | $2.04 | ||
| Q2 24 | $0.35 | $2.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $3.9B |
| Total Assets | $6.3B | $6.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $3.9B | ||
| Q3 25 | $2.7B | $3.9B | ||
| Q2 25 | $2.6B | $4.0B | ||
| Q1 25 | $2.3B | $4.1B | ||
| Q4 24 | $2.1B | $4.1B | ||
| Q3 24 | $2.0B | $4.0B | ||
| Q2 24 | $2.4B | $4.0B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $6.7B | ||
| Q3 25 | $7.5B | $7.0B | ||
| Q2 25 | $7.3B | $7.0B | ||
| Q1 25 | $6.8B | $7.0B | ||
| Q4 24 | $6.5B | $6.9B | ||
| Q3 24 | $6.4B | $6.8B | ||
| Q2 24 | $6.8B | $6.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $303.8M |
| Free Cash FlowOCF − Capex | — | $290.1M |
| FCF MarginFCF / Revenue | — | 17.1% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | — | 2.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | $287.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $303.8M | ||
| Q3 25 | $659.9M | $197.7M | ||
| Q2 25 | $303.0M | $168.4M | ||
| Q1 25 | $183.8M | $-334.3M | ||
| Q4 24 | $301.4M | $362.6M | ||
| Q3 24 | $199.5M | $-89.9M | ||
| Q2 24 | $279.4M | $61.5M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $290.1M | ||
| Q3 25 | $579.4M | $185.8M | ||
| Q2 25 | $208.9M | $156.9M | ||
| Q1 25 | $96.8M | $-345.5M | ||
| Q4 24 | $176.8M | $352.6M | ||
| Q3 24 | $88.3M | $-99.4M | ||
| Q2 24 | $213.3M | $51.2M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 17.1% | ||
| Q3 25 | 47.9% | 11.5% | ||
| Q2 25 | 18.1% | 10.3% | ||
| Q1 25 | 9.3% | -24.8% | ||
| Q4 24 | 15.9% | 17.6% | ||
| Q3 24 | 8.9% | -5.7% | ||
| Q2 24 | 21.2% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.8% | ||
| Q3 25 | 6.7% | 0.7% | ||
| Q2 25 | 8.1% | 0.8% | ||
| Q1 25 | 8.4% | 0.8% | ||
| Q4 24 | 11.2% | 0.5% | ||
| Q3 24 | 11.2% | 0.5% | ||
| Q2 24 | 6.6% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 2.99× | ||
| Q3 25 | 2.33× | 1.80× | ||
| Q2 25 | 1.69× | 1.56× | ||
| Q1 25 | 1.74× | -3.05× | ||
| Q4 24 | 1.99× | 1.90× | ||
| Q3 24 | 1.48× | -0.57× | ||
| Q2 24 | 1.95× | 0.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
KBH
| Home Building | $1.7B | 99% |
| Financial Service | $8.7M | 1% |
